Long time oral supplementation with branched-chain amino acids improves survival and decreases recurrences in patients with hepatocellular carcinoma

Japanese Journal of Gastroenterology

Volumn 105, Issue 6, 2008, Pages 808-816

  Tsuchiya, Kaoru ^b   Asahina, Yasuhiro ^b   Izumi, Namiki ^a  

^a MUSASHINO RED CROSS HOSPITAL   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRANCHED CHAIN AMINO ACID; CD18 ANTIGEN; CD5 ANTIGEN; CD8 ANTIGEN; LECTIN; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; RAPAMYCIN; VASCULOTROPIN;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; BODY MASS; CANCER PREVENTION; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIET THERAPY; EVENT FREE SURVIVAL; HUMAN; LIVER CELL CARCINOMA; LONG TERM CARE; LYMPHOCYTE; MAJOR CLINICAL STUDY; PROTEIN CALORIE MALNUTRITION; RETROSPECTIVE STUDY; RISK REDUCTION; SCORING SYSTEM; AGED; FEMALE; LIVER CIRRHOSIS; LIVER TUMOR; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; REVIEW; RISK FACTOR; TIME;

AGED; AMINO ACIDS, BRANCHED-CHAIN; BODY MASS INDEX; CARCINOMA, HEPATOCELLULAR; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 49049103220     PISSN: 04466586     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Oon CJ, Chen WN : Lymphoblastoid alpha-interferon in the prevention of hepatocellular carcinoma (HCC) in high-risk HBsAg-positive resected cirrhotic HCC cases : a 14-year follow-up. Cancer Invest 21 ; 394-399 : 2003
2. Ikeda K, Arase Y, Saitoh S, et al : Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor-A prospective randomized study of hepatitis C virus-related liver cancer. Hepatolgy 32 ; 228-232 : 2000
3. Kubo S, Nishiguchi S, Hirohashi K, et al : Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial. Ann Intern Med 134 ; 963-967 : 2001
4. Shiratori Y, Shiina S, Teratani T, et al : Interferon therapy after tumor ablation improves prognosis in patients with hepatocellular carcinoma associated with hepatitis C virus. Ann Intern Med 138 ; 299-306 : 2003 (Pubitemid 36205926)
5. Kato M, Miwa Y, Tajika M, et al : Preferential use of banched-chain amino acids as an energy substrate in patients with liver cirrhosis. Intern Med 37 ; 429-434 : 1998 (Pubitemid 128520846)
6. Yamato M, Muto Y, Yoshida T, et al : Clearance rate of plasma branched chain amino acid correlates significantly with blood ammonia level in patients with liver cirrhosis. Hepatol Res 3 ; 91-96 : 1995
7. Marchesini G, Bianchi G, Merli M, et al : Nutritional supplementation with branched-chain amino acids in advanced cirrhosis : a double-blind, randomized trial. Gastroenterolgy 124 ; 1792-1801 : 2003 (Pubitemid 36666776)
8. Muto Y, Sato S, Watanabe A, et al : Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. Clin Gastroenterol Hepatol 3 ; 705-713 : 2005
9. Ijichi C, Matsumura T, Tsuji T, et al : Branched-chain amino acids promote albumin synthesis in rat primary hepatocytes through the mTOR signal transduction system. Biochem Biophys Res Commun 303 ; 59-64 : 2003 (Pubitemid 36338207)
10. Greiwe JS, Kwon G, McDaniel ML, et al : Leucine and insulin activate p70 S6 kinase through different pathways in human skeletal muscle. Am J Physiol Endocrinol Metab 281 ; E466-E471 : 2001 (Pubitemid 32880919)
11. Matsumura T, Morinaga Y, Fujitani S, et al : Oral administration of branched-chain amino acids activates the mTOR signal in chirrhotic rat liver. Hepatol Res 33 ; 27-32 : 2005 (Pubitemid 41447880)
12. El-Serag HB, Tran T, Everhart JE : Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterolgy 126 ; 460-468 : 2004 (Pubitemid 38182303)
13. Hassan MM, Hwang LY, Hatten CJ, et al : Risk factors for hepatocellular carcinoma : synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 36 ; 1206-1213 : 2002
14. Balkau B, Kahn HS, Courbon D, et al : Hyperinsulinemia predicts fatal liver cancer but is inversely associated with fatal cancer at some other sites : the Paris Prospective Study. Diabetes Care 24 ; 843-849 : 2001 (Pubitemid 33636056)
15. Matsuo M : Association between diabetes mellitus and hepatocellular carcinoma : results of a hospital-and community-based case-control study. Kurume Med J 50 ; 91-98 : 2003
16. Hui JM, Sud A, Farrell GC, et al : Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression. Gastroenterolgy 125 ; 1695-1704 : 2003 (Pubitemid 37500434)
17. Nishitani S, Takehana K, Fujitani S, et al : Branched-chain amino acids improve glucose metabolism in rats with liver cirrhosis. Am J Physiol Gastrointest Liver Physiol 288 ; G1292-G1300 : 2005 (Pubitemid 40741084)
18. Nishitani S, Matsumura T, Fujitani S, et al : Leucine promotes glucose uptake in skeletal muscles of rats. Biochem Biophys Res Commun 299 ; 693-696 : 2002
19. KARKINOS 3 ; 905-912 : 1990
20. JJPEN 17 ; 331-337 : 1995
21. Cerra FB, Mazuski JE, Chute E, et al : Branched chain metabolic support. A prospective, randomized, double-blind trial in surgical stress. Ann Surg 199 ; 286-291 : 1984
22. Kakazu E, Kanno N, Ueno Y, et al : Extracellular branched-chain amino acids, especially valine, regulate maturation and function of monocyte-derived dendritic cells. J Immunol 179 ; 7137-7146 : 2007
23. Nakamura I, Ochiai K, Imai Y, et al : Restoration of innate host defense responses by oral supplementation of branched-chain amino acids in decompensated cirrhotic patients. Hepatol Res 37 ; 1062-1067 : 2007
24. Winnock M, Barcina MG, Lukomska B, et al : Liver-associated lymphocytes : role in tumor defence. Semin Liver Dis 13 ; 81-92 : 1993
25. Tsukishiro T, Shimizu Y, Higuchi K, et al : Effect of branched-chain amino acids on the composition and cytolytic activity of liver-associated lymphocytes in rats. J Gastroenterol Hepatol 15 ; 849-859 : 2000
26. Murata K, Moriyama M : Isoleucine, an essential amino acid, prevents liver metastases of colon cancer by antiangiogenesis. Cancer Res 67 ; 3263-3268 : 2007
27. Saito Y, Saito H, Nakamura M, et al : Effect of the molar ratio of branched-chain to aromatic amino acids on growth and albumin mRNA expression of human liver cancer cell lines in a serum-free medium. Nutr Cancer 39 ; 126-131 : 2001
28. Muto Y, Saito S, Watanabe A, et al : Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis. Hepatol Res 35 ; 204-214 : 2006
29. Togo S, Tanaka K, Morioka D, et al : Usefulness of granular BCAA after hepatectomy for liver cancer complicated with liver cirrhosis. Nutrition 21 ; 480-486 : 2005
30. Nishiguchi S, Habu D : Effect of oral supplementation with branched-chain amino acid granules in the early stage of cirrhosis. Hepatol Res 30S ; 36-41 : 2004
31. Lautz HU, Selberg O, Körber J, et al : Protein-calorie malnutrition in liver cirrhosis. Clin Investig 70 ; 478-486 : 1992
32. Fukushima H, Miwa Y, Ida E, et al : Nocturnal branched-chain amino acid administration improves protein metabolism in patients with liver cirrhosis : comparison with daytime administration. JPEN J Parenter Enteral Nutr 27 ; 315-322 : 2003
33. Jpn Pharmacol Ther 33 ; 19-24 : 2005
34. Jpn Pharmacol Ther 32 ; 121-125 : 2004